» Articles » PMID: 38207093

Deep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes

Abstract

Computed tomography (CT) enables noninvasive diagnosis of usual interstitial pneumonia (UIP), but enhanced image analyses are needed to overcome the limitations of visual assessment. Apply multiple instance learning (MIL) to develop an explainable deep learning algorithm for prediction of UIP from CT and validate its performance in independent cohorts. We trained an MIL algorithm using a pooled dataset ( = 2,143) and tested it in three independent populations: data from a prior publication ( = 127), a single-institution clinical cohort ( = 239), and a national registry of patients with pulmonary fibrosis ( = 979). We tested UIP classification performance using receiver operating characteristic analysis, with histologic UIP as ground truth. Cox proportional hazards and linear mixed-effects models were used to examine associations between MIL predictions and survival or longitudinal FVC. In two cohorts with biopsy data, MIL improved accuracy for histologic UIP (area under the curve, 0.77 [ = 127] and 0.79 [ = 239]) compared with visual assessment (area under the curve, 0.65 and 0.71). In cohorts with survival data, MIL-UIP classifications were significant for mortality ( = 239, mortality to April 2021: unadjusted hazard ratio, 3.1; 95% confidence interval [CI], 1.96-4.91;  < 0.001; and  = 979, mortality to July 2022: unadjusted hazard ratio, 3.64; 95% CI, 2.66-4.97;  < 0.001). Individuals classified as UIP positive by the algorithm had a significantly greater annual decline in FVC than those classified as UIP negative (-88 ml/yr vs. -45 ml/yr;  = 979;  < 0.01), adjusting for extent of lung fibrosis. Computerized assessment using MIL identifies clinically significant features of UIP on CT. Such a method could improve confidence in radiologic assessment of patients with interstitial lung disease, potentially enabling earlier and more precise diagnosis.

Citing Articles

Extent of lung fibrosis is of greater prognostic importance than HRCT pattern in patients with progressive pulmonary fibrosis: data from the ILD-PRO registry.

Swaminathan A, Weber J, Todd J, Palmer S, Neely M, Whelan T Respir Res. 2025; 26(1):73.

PMID: 40022059 PMC: 11871617. DOI: 10.1186/s12931-025-03136-6.


Potential of phosphodiesterase 4B inhibition in the treatment of progressive pulmonary fibrosis.

Keith R, Nambiar A Ther Adv Respir Dis. 2025; 19:17534666241309795.

PMID: 39745090 PMC: 11694302. DOI: 10.1177/17534666241309795.


Quantitative Chest CT Analysis: Three Different Approaches to Quantify the Burden of Viral Interstitial Pneumonia Using COVID-19 as a Paradigm.

Fanni S, Colligiani L, Volpi F, Novaria L, Tonerini M, Airoldi C J Clin Med. 2024; 13(23).

PMID: 39685766 PMC: 11642375. DOI: 10.3390/jcm13237308.


From pixels to prognosis: unlocking the potential of deep learning in fibrotic lung disease imaging analysis.

de la Orden Kett Morais S, Felder F, Walsh S Br J Radiol. 2024; 97(1161):1517-1525.

PMID: 38781513 PMC: 11332672. DOI: 10.1093/bjr/tqae108.


Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine.

Adegunsoye A, Kropski J, Behr J, Blackwell T, Corte T, Cottin V Am J Respir Crit Care Med. 2024; 210(4):401-423.

PMID: 38573068 PMC: 11351799. DOI: 10.1164/rccm.202401-0238SO.